Eltek (NASDAQ:ELTK), an Israeli manufacturer of technologically advanced printed circuit boards primarily serving defense, medical and industrial applications, on Monday reported full-year 2025 revenue of $51.8 million, an increase of 11% from the prior year.
The company posted GAAP net income of $0.8 million, or $0.12 per diluted share, and EBITDA of $4.5 million, representing 9% of revenues.
Fourth-quarter revenue totaled $13.2 million, with a net loss of $0.3 million for the period.
Profitability was pressured by several transitional factors, including the ongoing implementation of a manufacturing transition to support higher-complexity products, investments in a new plating line, workforce ramp-up costs and a roughly 13% depreciation of the U.S. dollar against the Israeli shekel that generated an estimated $2.2 million negative impact on reported results.
Despite these headwinds, Eltek cited strong underlying demand in its core defense and medical PCB segments, where customers continued to seek high-reliability, advanced-technology boards.